Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies-Reference-Cited by-同舟云学术

Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies

Published:2005-01 Issue:2 Volume:128 Page:184-191
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

de Greef Georgine E.,van Putten Wim L. J.,Boogaerts Marc,Huijgens Peter C.,Verdonck Leo F.,Vellenga Edo,Theobald Matthias,Jacky Emanuel,Lowenberg Bob, ,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05285.x/fullpdf

Reference18 articles.

1. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

2. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

3. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

4. Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies;Bone Marrow Transplantation;2024-05-23

2. Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection;Hematology, Transfusion and Cell Therapy;2023-12

3. Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia;Blood Cancer Journal;2023-09-04

4. Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response;British Journal of Haematology;2023-08-04

5. Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study;Clinical and Translational Science;2023-07-28